Pathway ID |
Pathway Name |
p-Value |
Adjusted p-Value |
Enriched Genes |
hsa03320 |
PPAR signaling pathway_Homo sapiens_hsa03320 |
1.301E-10 |
1.692E-08 |
FABP2; FABP3; FABP4; FABP5; PPARA; PPARD |
hsa04210 |
Apoptosis_Homo sapiens_hsa04210 |
1.837E-05 |
7.040E-04 |
CASP7; LMNA; MAPK1; TP53 |
hsa05161 |
Hepatitis B_Homo sapiens_hsa05161 |
2.166E-05 |
7.040E-04 |
EP300; MAPK1; TP53; TLR2 |
hsa00910 |
Nitrogen metabolism_Homo sapiens_hsa00910 |
8.939E-07 |
5.810E-05 |
CA12; CA7; CA9 |
hsa05134 |
Legionellosis_Homo sapiens_hsa05134 |
3.352E-05 |
8.136E-04 |
CASP7; CASP1; TLR2 |
hsa05010 |
Alzheimer's disease_Homo sapiens_hsa05010 |
3.755E-05 |
8.136E-04 |
CASP7; MAPK1; MAPT; HSD17B10 |
hsa05215 |
Prostate cancer_Homo sapiens_hsa05215 |
1.414E-04 |
2.298E-03 |
EP300; MAPK1; TP53 |
hsa05133 |
Pertussis_Homo sapiens_hsa05133 |
8.499E-05 |
1.578E-03 |
CASP7; CASP1; MAPK1 |
hsa04919 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 |
3.253E-04 |
4.699E-03 |
EP300; MAPK1; TP53 |
hsa05160 |
Hepatitis C_Homo sapiens_hsa05160 |
4.619E-04 |
5.460E-03 |
MAPK1; PPARA; TP53 |
hsa05200 |
Pathways in cancer_Homo sapiens_hsa05200 |
1.004E-03 |
8.234E-03 |
EP300; MAPK1; TP53; PPARD |
hsa04310 |
Wnt signaling pathway_Homo sapiens_hsa04310 |
5.592E-04 |
5.592E-03 |
EP300; TP53; PPARD |
hsa05164 |
Influenza A_Homo sapiens_hsa05164 |
1.025E-03 |
8.234E-03 |
CASP1; EP300; MAPK1 |
hsa05152 |
Tuberculosis_Homo sapiens_hsa05152 |
1.077E-03 |
8.234E-03 |
EP300; MAPK1; TLR2 |
hsa05205 |
Proteoglycans in cancer_Homo sapiens_hsa05205 |
1.571E-03 |
9.156E-03 |
MAPK1; TP53; TLR2 |
hsa04024 |
cAMP signaling pathway_Homo sapiens_hsa04024 |
1.484E-03 |
9.156E-03 |
EP300; MAPK1; PPARA |
hsa05216 |
Thyroid cancer_Homo sapiens_hsa05216 |
5.040E-04 |
5.460E-03 |
MAPK1; TP53 |
hsa05203 |
Viral carcinogenesis_Homo sapiens_hsa05203 |
1.616E-03 |
9.156E-03 |
EP300; MAPK1; TP53 |
hsa05168 |
Herpes simplex infection_Homo sapiens_hsa05168 |
1.203E-03 |
8.691E-03 |
EP300; TP53; TLR2 |
hsa05219 |
Bladder cancer_Homo sapiens_hsa05219 |
1.009E-03 |
8.234E-03 |
MAPK1; TP53 |
hsa00591 |
Linoleic acid metabolism_Homo sapiens_hsa00591 |
5.040E-04 |
5.460E-03 |
CYP1A2; ALOX15 |
hsa05223 |
Non-small cell lung cancer_Homo sapiens_hsa05223 |
1.876E-03 |
9.714E-03 |
MAPK1; TP53 |
hsa05213 |
Endometrial cancer_Homo sapiens_hsa05213 |
1.620E-03 |
9.156E-03 |
MAPK1; TP53 |
hsa04010 |
MAPK signaling pathway_Homo sapiens_hsa04010 |
3.004E-03 |
1.112E-02 |
MAPK1; MAPT; TP53 |
hsa05221 |
Acute myeloid leukemia_Homo sapiens_hsa05221 |
1.943E-03 |
9.714E-03 |
MAPK1; PPARD |
hsa05014 |
Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 |
1.559E-03 |
9.156E-03 |
CASP1; TP53 |
hsa05214 |
Glioma_Homo sapiens_hsa05214 |
2.518E-03 |
1.053E-02 |
MAPK1; TP53 |
hsa05210 |
Colorectal cancer_Homo sapiens_hsa05210 |
2.294E-03 |
1.053E-02 |
MAPK1; TP53 |
hsa05211 |
Renal cell carcinoma_Homo sapiens_hsa05211 |
2.595E-03 |
1.053E-02 |
EP300; MAPK1 |
hsa05212 |
Pancreatic cancer_Homo sapiens_hsa05212 |
2.595E-03 |
1.053E-02 |
MAPK1; TP53 |
hsa04621 |
NOD-like receptor signaling pathway_Homo sapiens_hsa04621 |
1.943E-03 |
9.714E-03 |
CASP1; MAPK1 |
hsa05206 |
MicroRNAs in cancer_Homo sapiens_hsa05206 |
4.607E-03 |
1.461E-02 |
EP300; MAPK1; TP53 |
hsa04720 |
Long-term potentiation_Homo sapiens_hsa04720 |
2.595E-03 |
1.053E-02 |
EP300; MAPK1 |
hsa00830 |
Retinol metabolism_Homo sapiens_hsa00830 |
2.518E-03 |
1.053E-02 |
CYP1A2; ALDH1A1 |
hsa05218 |
Melanoma_Homo sapiens_hsa05218 |
2.996E-03 |
1.112E-02 |
MAPK1; TP53 |
hsa05230 |
Central carbon metabolism in cancer_Homo sapiens_hsa05230 |
2.673E-03 |
1.053E-02 |
MAPK1; TP53 |
hsa05220 |
Chronic myeloid leukemia_Homo sapiens_hsa05220 |
3.164E-03 |
1.112E-02 |
MAPK1; TP53 |
hsa04151 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 |
6.756E-03 |
1.830E-02 |
MAPK1; TP53; TLR2 |
hsa05140 |
Leishmaniasis_Homo sapiens_hsa05140 |
3.164E-03 |
1.112E-02 |
MAPK1; TLR2 |
hsa04350 |
TGF-beta signaling pathway_Homo sapiens_hsa04350 |
4.164E-03 |
1.388E-02 |
EP300; MAPK1 |
hsa04916 |
Melanogenesis_Homo sapiens_hsa04916 |
5.848E-03 |
1.761E-02 |
EP300; MAPK1 |
hsa04922 |
Glucagon signaling pathway_Homo sapiens_hsa04922 |
5.962E-03 |
1.761E-02 |
EP300; PPARA |
hsa04520 |
Adherens junction_Homo sapiens_hsa04520 |
3.249E-03 |
1.112E-02 |
EP300; MAPK1 |
hsa04066 |
HIF-1 signaling pathway_Homo sapiens_hsa04066 |
6.193E-03 |
1.783E-02 |
EP300; MAPK1 |
hsa04620 |
Toll-like receptor signaling pathway_Homo sapiens_hsa04620 |
6.547E-03 |
1.811E-02 |
MAPK1; TLR2 |
hsa05142 |
Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 |
6.310E-03 |
1.783E-02 |
MAPK1; TLR2 |
hsa04668 |
TNF signaling pathway_Homo sapiens_hsa04668 |
7.033E-03 |
1.866E-02 |
CASP7; MAPK1 |
hsa05132 |
Salmonella infection_Homo sapiens_hsa05132 |
4.360E-03 |
1.417E-02 |
CASP1; MAPK1 |
hsa04726 |
Serotonergic synapse_Homo sapiens_hsa04726 |
7.282E-03 |
1.893E-02 |
ALOX15; MAPK1 |
hsa05145 |
Toxoplasmosis_Homo sapiens_hsa05145 |
8.053E-03 |
2.040E-02 |
MAPK1; TLR2 |
hsa04722 |
Neurotrophin signaling pathway_Homo sapiens_hsa04722 |
8.318E-03 |
2.040E-02 |
MAPK1; TP53 |
hsa04932 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 |
1.291E-02 |
2.945E-02 |
CASP7; PPARA |
hsa05162 |
Measles_Homo sapiens_hsa05162 |
1.058E-02 |
2.455E-02 |
TP53; TLR2 |
hsa04071 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 |
8.318E-03 |
2.040E-02 |
MAPK1; TP53 |
hsa04068 |
FoxO signaling pathway_Homo sapiens_hsa04068 |
1.013E-02 |
2.395E-02 |
EP300; MAPK1 |
hsa05169 |
Epstein-Barr virus infection_Homo sapiens_hsa05169 |
2.234E-02 |
4.923E-02 |
EP300; TP53 |
hsa05016 |
Huntington's disease_Homo sapiens_hsa05016 |
2.052E-02 |
4.599E-02 |
EP300; TP53 |
hsa04110 |
Cell cycle_Homo sapiens_hsa04110 |
8.860E-03 |
2.133E-02 |
EP300; TP53 |
hsa00232 |
Caffeine metabolism_Homo sapiens_hsa00232 |
5.737E-03 |
1.761E-02 |
CYP1A2 |